Article
Ubiquitin-specific protease 14 promotes prostate cancer progression through deubiquitinating the transcriptional factor ATF2.
Biochemical and biophysical research communications - 26 Mar 2020
Geng Lin, Chen Xing, Zhang Meng, Luo Zhenkai
Abstract excerpt
Activating Transcription Factor 2 (ATF2) is a member of the ATF/CREB bZIP family of transcription factors and an oncogene in prostate cancer. ATF2 has been reported to be a critical substrate of the CUL3-SPOP-RBX1 E3 ubiquitin ligase complex and the recurrent somatic mutation of SPOP has been believed to be a key feature of prostate cancer. However, the deubiquitinating enzyme required for ATF2 stabilization is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
